R Visconti

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity
    R Visconti
    Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892 1820, USA
    Blood 96:1844-52. 2000
  2. ncbi The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common gamma chain-using cytokines
    M Gadina
    Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, NIAMS, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Biol Chem 275:26959-66. 2000
  3. ncbi Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation
    R A Ortmann
    Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Arthritis Res 2:16-32. 2000
  4. ncbi Jaks and stats as therapeutic targets
    J J O'Shea
    National Institutes of Health, Bethesda, MD 20892 1820, USA
    Ann Rheum Dis 59:i115-8. 2000
  5. ncbi Ret-mediated mitogenesis requires Src kinase activity
    R M Melillo
    Centro di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia di Napoli, Universita di Napoli Federico II, Naples, Italy
    Cancer Res 59:1120-6. 1999
  6. ncbi Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B
    D Salvatore
    Centro di Endocrinologia ed Oncologia Sperimentale del CNR, , Italy
    Cancer Res 61:1426-31. 2001
  7. ncbi The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane
    C Monaco
    Centro di Endocrinologia ed Oncologia Sperimentale del CNR, c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, , , Via S. Pansini 5, 80131 Naples, Italy
    Oncogene 20:599-608. 2001

Collaborators

Detail Information

Publications7

  1. ncbi Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity
    R Visconti
    Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892 1820, USA
    Blood 96:1844-52. 2000
    ..Blood. 2000;96:1844-1852)..
  2. ncbi The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common gamma chain-using cytokines
    M Gadina
    Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, NIAMS, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Biol Chem 275:26959-66. 2000
    ..Therefore, up-regulation and activation of Gab2 may be important in linking the IL-2 receptor to activation of MAPK and may be an important means of achieving specificity in cytokine signaling...
  3. ncbi Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation
    R A Ortmann
    Lymphocyte Cell Biology Section, Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Arthritis Res 2:16-32. 2000
    ..It is hoped that further elucidation of cytokine signaling through these pathways will not only allow for a better comprehension of the etiopathogenesis of rheumatologic illnesses, but may also direct future treatment options...
  4. ncbi Jaks and stats as therapeutic targets
    J J O'Shea
    National Institutes of Health, Bethesda, MD 20892 1820, USA
    Ann Rheum Dis 59:i115-8. 2000
    ..The possibility that these molecules could be targeted to produce novel immunosuppressive compounds is considered in this review...
  5. ncbi Ret-mediated mitogenesis requires Src kinase activity
    R M Melillo
    Centro di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia di Napoli, Universita di Napoli Federico II, Naples, Italy
    Cancer Res 59:1120-6. 1999
    ..These experiments demonstrate that activated Ret is able to bind and stimulate c-Src kinase and that Src activation is essential for the mitogenic activity of Ret...
  6. ncbi Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B
    D Salvatore
    Centro di Endocrinologia ed Oncologia Sperimentale del CNR, , Italy
    Cancer Res 61:1426-31. 2001
    ..The more efficient triggering of these pathways may account for the difference between MEN2A and MEN2B syndromes...
  7. ncbi The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane
    C Monaco
    Centro di Endocrinologia ed Oncologia Sperimentale del CNR, c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, , , Via S. Pansini 5, 80131 Naples, Italy
    Oncogene 20:599-608. 2001
    ....